XML 20 R57.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Information for the Company and Its Subsidiaries (Cash Flow Statements) (Details) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Cash flows from operating activities:    
Net cash flows provided by operating activities $ 153,581 $ 152,550
Cash flows from investing activities:    
Acquisition of interests in surgery centers and related transactions (24,437) (18,346)
Acquisition of property and equipment (16,075) (12,472)
Proceeds from sale of interests in surgery centers 2,092 0
Other (1,381) 55
Net cash flows used in investing activities (39,801) (30,763)
Cash flows from financing activities:    
Proceeds from long-term borrowings 74,246 70,922
Repayment on long-term borrowings (102,326) (96,222)
Distributions to noncontrolling interests (92,010) (91,526)
Changes In Intercompany Balances 0 0
Other financing activities, net 381 (11,436)
Net cash flows provided by (used in) financing activities (119,709) (128,262)
Net increase (decrease) in cash and cash equivalents (5,929) (6,475)
Cash and cash equivalents, beginning of period 50,840 46,398
Cash and cash equivalents, end of period 44,911 39,923
Consolidation, Eliminations [Member]
   
Cash flows from operating activities:    
Net cash flows provided by operating activities (179,130) (187,493)
Cash flows from investing activities:    
Acquisition of interests in surgery centers and related transactions 2,443 78
Acquisition of property and equipment 0 0
Proceeds from sale of interests in surgery centers 0  
Other 0 0
Net cash flows used in investing activities 2,443 78
Cash flows from financing activities:    
Proceeds from long-term borrowings 0 0
Repayment on long-term borrowings 0 0
Distributions to noncontrolling interests 179,130 187,493
Changes In Intercompany Balances 0 0
Other financing activities, net (2,443) (78)
Net cash flows provided by (used in) financing activities 176,687 187,415
Net increase (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents, beginning of period 0 0
Cash and cash equivalents, end of period 0 0
Parent Company [Member]
   
Cash flows from operating activities:    
Net cash flows provided by operating activities 27,919 32,189
Cash flows from investing activities:    
Acquisition of interests in surgery centers and related transactions 0 0
Acquisition of property and equipment (1,949) (1,189)
Proceeds from sale of interests in surgery centers 0  
Other (1,259) 0
Net cash flows used in investing activities (3,208) (1,189)
Cash flows from financing activities:    
Proceeds from long-term borrowings 70,000 66,700
Repayment on long-term borrowings (96,358) (89,224)
Distributions to noncontrolling interests 0 0
Changes In Intercompany Balances (1,020) 1,431
Other financing activities, net (207) (12,371)
Net cash flows provided by (used in) financing activities (27,585) (33,464)
Net increase (decrease) in cash and cash equivalents (2,874) (2,464)
Cash and cash equivalents, beginning of period 6,710 7,259
Cash and cash equivalents, end of period 3,836 4,795
Guarantor Subsidiaries [Member]
   
Cash flows from operating activities:    
Net cash flows provided by operating activities 102,284 102,630
Cash flows from investing activities:    
Acquisition of interests in surgery centers and related transactions (26,880) (18,424)
Acquisition of property and equipment 0 0
Proceeds from sale of interests in surgery centers 2,092  
Other (122) 55
Net cash flows used in investing activities (24,910) (18,369)
Cash flows from financing activities:    
Proceeds from long-term borrowings 0 0
Repayment on long-term borrowings 0 0
Distributions to noncontrolling interests (76,846) (84,863)
Changes In Intercompany Balances 0 0
Other financing activities, net (528) 602
Net cash flows provided by (used in) financing activities (77,374) (84,261)
Net increase (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents, beginning of period 0 0
Cash and cash equivalents, end of period 0 0
Non-Guarantor Subsidiaries [Member]
   
Cash flows from operating activities:    
Net cash flows provided by operating activities 202,508 205,224
Cash flows from investing activities:    
Acquisition of interests in surgery centers and related transactions 0 0
Acquisition of property and equipment (14,126) (11,283)
Proceeds from sale of interests in surgery centers 0  
Other 0 0
Net cash flows used in investing activities (14,126) (11,283)
Cash flows from financing activities:    
Proceeds from long-term borrowings 4,246 4,222
Repayment on long-term borrowings (5,968) (6,998)
Distributions to noncontrolling interests (194,294) (194,156)
Changes In Intercompany Balances 1,020 (1,431)
Other financing activities, net 3,559 411
Net cash flows provided by (used in) financing activities (191,437) (197,952)
Net increase (decrease) in cash and cash equivalents (3,055) (4,011)
Cash and cash equivalents, beginning of period 44,130 39,139
Cash and cash equivalents, end of period $ 41,075 $ 35,128